Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity
Nov 28, 2025, 16:46

Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity

Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:

“Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity

For decades, plasma was viewed simply as a life-saving medical resource. Today, it has become something far more powerful: a strategic asset shaping national healthcare security, global trade, and geopolitical influence.

In this issue of Blood and Plasma Pulse, we explore a critical but under-discussed reality:

  • Why plasma is no longer just a clinical input, but a tool of national resilience
  • How a handful of countries now control the majority of global plasma supply
  • What “plasma sovereignty” means for healthcare systems and patient access
  • How plasma is influencing international alliances, supply agreements, and policy decisions

As demand for plasma-derived therapies accelerates and supply remains highly concentrated, the question is no longer about who donates plasma but who controls its future.

This edition dives into the emerging concept of Plasma Diplomacy, where healthcare, strategy, economics, and global cooperation intersect through a single biological resource.

Is plasma becoming the next strategic healthcare commodity on the global stage?”

Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity

Read full paper here.

Stay updated with Hemostasis Today.